Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium

Vinflunine is the only cytotoxic agent tested as a second line therapy in transitional cell carcinoma of the urothelium in a phase III trial. It is not largely employed in clinical practice because of the high incidence of grade 3–4 toxicity. We evaluated efficacy and safety of Vinflunine at the dos...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Schinzari, Giovanni, Rossi, Ernesto, Pierconti, Francesco, Garufi, Giovanna, Monterisi, Santa, Strippoli, Antonia, D’Argento, Ettore, Cassano, Alessandra, Barone, Carlo
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2018
Subjects:
Clinical Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5823567/
https://ncbi.nlm.nih.gov/pubmed/29492236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24162
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items